Medicare Enrolled
Dr. Shankar Kandaswamy, M.D.
Pulmonary Disease · Newnan, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kandaswamy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kandaswamy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kandaswamy
Dr. Shankar Kandaswamy is a pulmonary disease specialist in Newnan, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kandaswamy performed 2,513 Medicare services across 1,870 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kandaswamy received a total of $30,191 from 61 pharmaceutical and/or device companies across 946 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kandaswamy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in GA
$30,191 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,513
Medicare services
Top 11% in GA for pulmonary disease
1,870
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~126 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
639 | $85 | $370 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
412 | $121 | $496 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
206 | $11 | $54 |
| New patient office visit, complex (60-74 min) | 195 | $152 | $705 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
146 | $8 | $23 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
99 | $37 | $184 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
98 | $39 | $189 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
97 | $26 | $203 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
82 | $22 | $107 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
69 | $0 | $1 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
63 | $31 | $57 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
60 | $71 | $219 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $66 | $253 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
52 | $10 | $69 |
| Chest X-ray, 1 view An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity. |
43 | $8 | $43 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
40 | $25 | $117 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
40 | $164 | $762 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
33 | $93 | $355 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
24 | $6 | $62 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
19 | $31 | $57 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
15 | $47 | $219 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
13 | $8 | $44 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
11 | $17 | $121 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$30,191
Total received (2018-2024)
Avg $4,313/year across 7 years
Top 7% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
946
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,837 (72.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,874 (26.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$481 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,921
2023
$12,107
2022
$3,047
2021
$2,991
2020
$3,262
2019
$2,896
2018
$1,967
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$742
AstraZeneca Pharmaceuticals LP
$724
GENZYME CORPORATION
$444
JAZZ PHARMACEUTICALS INC.
$356
HARMONY BIOSCIENCES LLC
$271
Takeda Pharmaceuticals U.S.A., Inc.
$178
Merck Sharp & Dohme LLC
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Grifols USA, LLC
$101
United Therapeutics Corporation
$98
Electromed, Inc.
$96
Harmony Biosciences Llc
$76
Amgen Inc.
$66
Axsome Therapeutics, Inc.
$64
Regeneron Healthcare Solutions, Inc.
$57
Baxter Healthcare
$47
PFIZER INC.
$46
Mylan Specialty L.P.
$39
Bayer Healthcare Pharmaceuticals Inc.
$36
3B Medical, Inc.
$34
Philips North America LLC
$33
Insmed, Inc.
$22
ABBVIE INC.
$21
Pulmonx Corporation
$19
ANI Pharmaceuticals, Inc.
$18
Vifor Pharma, Inc.
$18
Inspire Medical Systems, Inc.
$15
Resmed Corp
$15
Tactile Systems Technology Inc
$15
Top 3 companies account for 48.7% of 2024 payments
All-time payments by company (2018-2024) ›
Insmed, Inc.
$8,304
GlaxoSmithKline, LLC.
$3,596
AstraZeneca Pharmaceuticals LP
$3,043
Actelion Pharmaceuticals US, Inc.
$1,563
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,362
GENZYME CORPORATION
$1,339
Sunovion Pharmaceuticals Inc.
$1,282
Mylan Specialty L.P.
$739
Harmony Biosciences LLC
$731
JAZZ PHARMACEUTICALS INC.
$641
Grifols USA, LLC
$615
United Therapeutics Corporation
$595
Takeda Pharmaceuticals U.S.A., Inc.
$583
Electromed, Inc.
$547
HARMONY BIOSCIENCES LLC
$493
Regeneron Healthcare Solutions, Inc.
$491
Shire North American Group Inc
$437
PFIZER INC.
$401
CSL Behring
$278
Genentech USA, Inc.
$195
Baxter Healthcare
$195
Eisai Inc.
$175
Mallinckrodt Hospital Products Inc.
$159
Bayer HealthCare Pharmaceuticals Inc.
$156
EISAI INC.
$152
Merck Sharp & Dohme LLC
$146
Mallinckrodt Enterprises LLC
$145
Axsome Therapeutics, Inc.
$136
Pulmonx Corporation
$135
SANOFI-AVENTIS U.S. LLC
$132
Johnson & Johnson Health Care Systems Inc.
$129
Merck Sharp & Dohme Corporation
$110
ANI Pharmaceuticals, Inc.
$108
Amgen Inc.
$106
Inspire Medical Systems, Inc.
$78
Bayer Healthcare Pharmaceuticals Inc.
$77
Harmony Biosciences Llc
$76
Mallinckrodt LLC
$67
Teva Pharmaceuticals USA, Inc.
$66
Circassia Pharmaceuticals Inc
$53
Inogen, Inc.
$50
Jazz Pharmaceuticals Inc.
$48
Advanced Respiratory, Inc
$46
Medtronic USA, Inc.
$45
Phadia US Inc.
$39
Lilly USA, LLC
$35
3B Medical, Inc.
$34
Philips North America LLC
$33
Novo Nordisk Inc
$26
Philips Electronics North America Corporation
$22
Novartis Pharmaceuticals Corporation
$22
Optinose US, Inc.
$22
ABBVIE INC.
$21
Vifor Pharma, Inc.
$18
Janssen Pharmaceuticals, Inc
$15
ADMA BioManufacturing LLC
$15
Resmed Corp
$15
Tactile Systems Technology Inc
$15
Allergan, Inc.
$14
Veran Medical Technologies, Inc.
$13
Allergan Inc.
$11
Top 3 companies account for 49.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · 120V · 60Hz · ACTHAR · AIRSENSE · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · CERDELGA · CHANTIX · CHARTIS CATHETER · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DALVANCE · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · Dymista · Esbriet · FARXIGA · FASENRA · FUSION · Flexitouch Plus · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · InogenOne · JANUVIA · LONHALA MAGNAIR · LUMIZYME · LUNA · LYRICA · Life 2000 Ventilation System · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENITRAM · Ozempic · PANZYGA · POMPE - DISEASE · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · SMARTVEST · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · The VisiVest Airway Clearance System · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xembify · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (72%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for pulmonary disease in GA.
Geographic Context
Pulmonary diseases within 10 mi
9
Per 100K population
6.0
County median income
$94,142
Nearest hospital
PIEDMONT NEWNAN HOSPITAL, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kandaswamy is a clinical cardiology specialist, with above-average Medicare volume (top 11% in GA), with low-engagement industry engagement in the top 7% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kandaswamy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kandaswamy performed 639 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kandaswamy receive payments from pharmaceutical companies?
Yes. Dr. Kandaswamy received a total of $30,191 from 61 companies across 946 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kandaswamy's costs compare to other pulmonary diseases in Newnan?
Dr. Kandaswamy's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kandaswamy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Newnan
Browse pulmonary diseases in Newnan ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology